NCT05028257View on ClinicalTrials.gov

Allergy and COVID-19 Vaccines

PHASE3CompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

May 22, 2023

Study Completion Date

May 22, 2023

Conditions
Anaphylactic ReactionVaccine Reaction
Interventions
BIOLOGICAL

COVID-19 Vaccines

Pursuit of vaccination in case of anaphylactic reaction

Trial Locations (1)

75020

Tenon Hospital APHP dermatology and allergology department, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT05028257 - Allergy and COVID-19 Vaccines | Biotech Hunter | Biotech Hunter